Berlinger Special AG: Doping Sample Security is the Paramount Priority

Food and Healthcare Press Releases Wednesday January 31, 2018 09:52
GANTERSCHWIL, Switzerland--31 Jan--PRNewswire/InfoQuest

The doping samples taken at the coming Olympic Winter Games in PyeongChang, South Korea will be capable of being securely closed and stored. Sample bottle manufacturer Berlinger Special AG is currently assessing any security weaknesses in collaboration and close contact with the World Anti-Doping Agency (WADA) and is also planning additional security measures.

The secure handling and storage of doping samples - at the Olympic Winter Games and in general - is the mission and the goal of sample security bottle manufacturer Berlinger Special AG. In view of this, Berlinger Special AG takes seriously the recent video-documented tests by the team of investigative journalists, even though the testing methods used are not known, and even though their findings contradict the results of the extensive tests conducted both by Berlinger Special AG and by independent specialists on the bottles concerned, which showed in all cases that the bottles worked reliably when correctly handled.

(Photo: https://mma.prnewswire.com/media/635225/Berlinger_Special_AG_Doping_Security.jpg )
(Photo: https://mma.prnewswire.com/media/635224/Berlinger_Special_AG_Doping_Samples.jpg )

What cannot be said of the sample bottles currently used (as is claimed in the film) is that they cannot be distinguished from counterfeits: Berlinger Special AG can always identify its own products beyond any doubt, thanks to a number of secret company-specific features that are integrated into the product.

Improved closing mechanism under consideration

Should security shortcomings be confirmed, Berlinger Special AG will take additional measures to safeguard the samples collected at the coming Olympic Winter Games in PyeongChang. Among the options here, Berlinger Special AG is considering the use of doping sample containers with a modified closing mechanism that cannot be incorrectly handled. Corresponding trials are currently under way, and all the results of these will be made available.

Berlinger Special AG is making every possible effort, in collaboration with WADA and the IOC, to provide secure doping sample solutions that ensure clean competition and credible controls. The results of the current trials, and of any decisions taken in the light thereof, will be communicated without delay.

Further information:
Berlinger Special AG
Media Relations
c/o. KMES Partner I KLAUS
Hans Klaus
Basteiplatz 7
CH-8001 Zurich
Phone: +41-43-544-1744
Email: office@kmespartner.com
Source: Berlinger Special AG

Latest Press Release

Israel Ministry of Health Includes INSIGHTEC#s Focused Ultrasound Treatment for Medication-Refractory Essential Tremor as Part of Covered Health Services

INSIGHTEC(R), a commercial-stage medical technology company revolutionizing surgery with incisionless MR-guided focused ultrasound (MRgFUS) announced today that the Neuravive focused ultrasound treatment will be a covered service for essential tremor...

The ImplantCenter Marks a New Era in the Hungarian Private Dental Service

The ImplantCenter has recently opened the brand-new operating room suited for more complex treatments. This comes alongside numerous additions such as the launch of the four cosy apartments to rest after treatments at the clinic and an implant education...

Merck and Pfizer Provide Update on Phase III JAVELIN Lung 200 Trial of Avelumab Monotherapy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

Merck and Pfizer Inc. (NYSE: PFE) today announced results from the Phase III JAVELIN Lung 200 trial comparing avelumab* to docetaxel in patients with unresectable, recurrent or metastatic non-small cell lung cancer (NSCLC) whose disease progressed after...

PharmaMar Licenses Fully Synthetic Marine-derived Payloads to Seattle Genetics for Use in Drug Conjugates

PharmaMar (MCE: PHM) has announced today the signing of an exclusive licensing agreement with Seattle Genetics Inc. (SGEN: NASDAQ GS) under which Seattle Genetics receives exclusive worldwide rights to certain PharmaMar proprietary molecules for the...

After multiple failed procedures at other medical institutions, Colorado man successfully treated for Atrial Fibrillation at Texas Cardiac Arrhythmia Institute at St. David#s Medical Center

"I was thinking I was on top of the world," Wiseman said. "I was keeping myself in shape. I was taking care of myself mentally and physically. My relationship was solid." Then, during a routine medical exam while serving in the military in California,...

Related Topics